U.S. FDA panel recommends approval of NPS hormone replacement drug

(Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted 8-5 to recommend approval for Natpara, a hormone replacement therapy developed by NPS Pharmaceuticals Inc.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news